ID   VGFR1_HUMAN             Reviewed;         361 AA.
AC   P17948-8;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   12-OCT-2022, entry version 244.
DE   RecName: Full=Isoform 8 of Vascular endothelial growth factor receptor 1;
DE            Short=VEGFR-1;
DE            EC=2.7.10.1;
DE   AltName: Full=Fms-like tyrosine kinase 1;
DE            Short=FLT-1;
DE   AltName: Full=Tyrosine-protein kinase FRT;
DE   AltName: Full=Tyrosine-protein kinase receptor FLT;
DE            Short=FLT;
DE   AltName: Full=Vascular permeability factor receptor;
DE   Flags: Precursor;
GN   Name=FLT1; Synonyms=FLT, FRT, VEGFR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2158038;
RA   Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H.,
RA   Sato M.;
RT   "Nucleotide sequence and expression of a novel human receptor-type tyrosine
RT   kinase gene (flt) closely related to the fms family.";
RL   Oncogene 5:519-524(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF N-TERMINUS,
RP   SUBCELLULAR LOCATION (ISOFORM 2), INTERACTION WITH VEGFA, AND FUNCTION.
RC   TISSUE=Umbilical vein;
RX   PubMed=8248162; DOI=10.1073/pnas.90.22.10705;
RA   Kendall R.L., Thomas K.A.;
RT   "Inhibition of vascular endothelial cell growth factor activity by an
RT   endogenously encoded soluble receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10705-10709(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH VEGFA, AND
RP   GLYCOSYLATION.
RC   TISSUE=Umbilical vein;
RX   PubMed=10471394; DOI=10.1006/bbrc.1999.1282;
RA   Herley M.T., Yu Y., Whitney R.G., Sato J.D.;
RT   "Characterization of the VEGF binding site on the Flt-1 receptor.";
RL   Biochem. Biophys. Res. Commun. 262:731-738(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION IN LIGAND BINDING, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, ROLE IN PREECLAMPSIA, AND INDUCTION.
RX   PubMed=18515749; DOI=10.1161/circresaha.108.171504;
RA   Sela S., Itin A., Natanson-Yaron S., Greenfield C., Goldman-Wohl D.,
RA   Yagel S., Keshet E.;
RT   "A novel human-specific soluble vascular endothelial growth factor receptor
RT   1: cell-type-specific splicing and implications to vascular endothelial
RT   growth factor homeostasis and preeclampsia.";
RL   Circ. Res. 102:1566-1574(2008).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5; 6; 7 AND 8), ALTERNATIVE SPLICING,
RP   FUNCTION IN PHOSPHORYLATION OF SRC AND CANCER CELL INVASIVENESS, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20512933; DOI=10.1002/jcb.22584;
RA   Mezquita B., Mezquita J., Pau M., Mezquita C.;
RT   "A novel intracellular isoform of VEGFR-1 activates Src and promotes cell
RT   invasion in MDA-MB-231 breast cancer cells.";
RL   J. Cell. Biochem. 110:732-742(2010).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Mezquita J., Mezquita B., Pau M., Mezquita C.;
RT   "A new VEGFR1 receptor transcript coding for the extracellular domains of
RT   the protein followed by a C-terminal polyserine tail.";
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1018-1058, AND ALTERNATIVE SPLICING
RP   (ISOFORM 1).
RX   PubMed=3040650;
RA   Matsushime H., Yoshida M.C., Sasaki M., Shibuya M.;
RT   "A possible new member of tyrosine kinase family, human frt sequence, is
RT   highly conserved in vertebrates and located on human chromosome 13.";
RL   Jpn. J. Cancer Res. 78:655-661(1987).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE, CATALYTIC ACTIVITY, PHOSPHORYLATION AT TYR-914;
RP   TYR-1213; TYR-1242; TYR-1327 AND TYR-1333, MUTAGENESIS OF TYR-914;
RP   TYR-1213; TYR-1242; TYR-1327 AND TYR-1333, AND INTERACTION WITH PLCG; GRB2;
RP   CRK; NCK1 AND PTPN11.
RX   PubMed=9722576; DOI=10.1074/jbc.273.36.23410;
RA   Ito N., Wernstedt C., Engstrom U., Claesson-Welsh L.;
RT   "Identification of vascular endothelial growth factor receptor-1 tyrosine
RT   phosphorylation sites and binding of SH2 domain-containing molecules.";
RL   J. Biol. Chem. 273:23410-23418(1998).
RN   [15]
RP   INTERACTION WITH VEGFA, AUTOPHOSPHORYLATION, CATALYTIC ACTIVITY, FUNCTION
RP   IN PHOSPHORYLATION OF PLCG, AND ABSENCE OF MITOGENIC FUNCTION IN CULTURED
RP   FIBROBLASTS.
RX   PubMed=7824266;
RA   Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., Shibuya M.;
RT   "A unique signal transduction from FLT tyrosine kinase, a receptor for
RT   vascular endothelial growth factor VEGF.";
RL   Oncogene 10:135-147(1995).
RN   [16]
RP   FUNCTION IN CELL MIGRATION, FUNCTION IN VEGFA AND PGF SIGNALING, AND
RP   INDUCTION.
RX   PubMed=8605350;
RA   Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marme D.;
RT   "Migration of human monocytes in response to vascular endothelial growth
RT   factor (VEGF) is mediated via the VEGF receptor flt-1.";
RL   Blood 87:3336-3343(1996).
RN   [17]
RP   FUNCTION IN PHOSPHORYLATION OF PLCG AND ACTIVATION OF MAP KINASES,
RP   INTERACTION WITH PLCG, CATALYTIC ACTIVITY, MUTAGENESIS OF LYS-861 AND
RP   TYR-1169, AND PHOSPHORYLATION AT TYR-1169 AND TYR-1213.
RX   PubMed=9299537; DOI=10.1006/bbrc.1997.7327;
RA   Sawano A., Takahashi T., Yamaguchi S., Shibuya M.;
RT   "The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-
RT   1) is a major binding site for PLCgamma.";
RL   Biochem. Biophys. Res. Commun. 238:487-491(1997).
RN   [18]
RP   INTERACTION WITH PIK3R1; PTPN11 AND NCK1, AND PHOSPHORYLATION AT TYR-1213.
RX   PubMed=9600074; DOI=10.1006/bbrc.1998.8578;
RA   Igarashi K., Isohara T., Kato T., Shigeta K., Yamano T., Uno I.;
RT   "Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.";
RL   Biochem. Biophys. Res. Commun. 246:95-99(1998).
RN   [19]
RP   FUNCTION AS NEGATIVE REGULATOR OF KDR-MEDIATED CELL PROLIFERATION.
RX   PubMed=11141500; DOI=10.1016/s0002-9440(10)63965-x;
RA   Dunk C., Ahmed A.;
RT   "Vascular endothelial growth factor receptor-2-mediated mitogenesis is
RT   negatively regulated by vascular endothelial growth factor receptor-1 in
RT   tumor epithelial cells.";
RL   Am. J. Pathol. 158:265-273(2001).
RN   [20]
RP   INTERACTION WITH PIK3R1 AND VEGFA, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT
RP   TYR-1213, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   GLYCOSYLATION.
RX   PubMed=11513746; DOI=10.1042/0264-6021:3580465;
RA   Yu Y., Hulmes J.D., Herley M.T., Whitney R.G., Crabb J.W., Sato J.D.;
RT   "Direct identification of a major autophosphorylation site on vascular
RT   endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol
RT   3'-kinase binding.";
RL   Biochem. J. 358:465-472(2001).
RN   [21]
RP   FUNCTION IN PGF-MEDIATED CHORIOCARCINOMA CELL PROLIFERATION.
RX   PubMed=11811792; DOI=10.3109/08977190109001086;
RA   Angelucci C., Lama G., Iacopino F., Maglione D., Sica G.;
RT   "Effect of placenta growth factor-1 on proliferation and release of nitric
RT   oxide, cyclic AMP and cyclic GMP in human epithelial cells expressing the
RT   FLT-1 receptor.";
RL   Growth Factors 19:193-206(2001).
RN   [22]
RP   INTERACTION WITH KDR, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, AND FUNCTION
RP   IN VEGFA SIGNALING; PHOSPHORYLATION OF PLCG AND ACTIVATION OF
RP   PHOSPHATIDYLINOSITOL KINASE AND PHOSPHOLIPASE C.
RX   PubMed=11312102; DOI=10.1016/s1357-2725(01)00019-x;
RA   Huang K., Andersson C., Roomans G.M., Ito N., Claesson-Welsh L.;
RT   "Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers.";
RL   Int. J. Biochem. Cell Biol. 33:315-324(2001).
RN   [23]
RP   FUNCTION IN SIGNALING VIA ACTIVATION OF THE PHOSPHATIDYLINOSITOL KINASE
RP   PATHWAY AND POSITIVE REGULATION OF ANGIOGENESIS IN RESPONSE TO PGF AND
RP   VEGFA.
RX   PubMed=14633857; DOI=10.2337/diabetes.52.12.2959;
RA   Cai J., Ahmad S., Jiang W.G., Huang J., Kontos C.D., Boulton M., Ahmed A.;
RT   "Activation of vascular endothelial growth factor receptor-1 sustains
RT   angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase
RT   pathway in endothelial cells.";
RL   Diabetes 52:2959-2968(2003).
RN   [24]
RP   INTERACTION WITH PGF AND KDR, FUNCTION IN PHOSPHORYLATION OF KDR; VEGFA AND
RP   PGF SIGNALING, CATALYTIC ACTIVITY, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   PHOSPHORYLATION AT TYR-1213; TYR-1327 AND TYR-1309.
RX   PubMed=12796773; DOI=10.1038/nm884;
RA   Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D.,
RA   Kroll J., Plaisance S., De Mol M., Bono F., Kliche S., Fellbrich G.,
RA   Ballmer-Hofer K., Maglione D., Mayr-Beyrle U., Dewerchin M., Dombrowski S.,
RA   Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D.J., Persico G.,
RA   Herbert J.M., Communi D., Shibuya M., Collen D., Conway E.M., Carmeliet P.;
RT   "Role of PlGF in the intra- and intermolecular cross talk between the VEGF
RT   receptors Flt1 and Flk1.";
RL   Nat. Med. 9:936-943(2003).
RN   [25]
RP   INTERACTION WITH CBL AND CD2AP, UBIQUITINATION, AUTOPHOSPHORYLATION IN
RP   RESPONSE TO VEGFA, MUTAGENESIS OF TYR-1333, AND SUBCELLULAR LOCATION.
RX   PubMed=15001553; DOI=10.1096/fj.03-0767fje;
RA   Kobayashi S., Sawano A., Nojima Y., Shibuya M., Maru Y.;
RT   "The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation
RT   of Flt-1 (VEGFR-1).";
RL   FASEB J. 18:929-931(2004).
RN   [26]
RP   FUNCTION IN VEGFA AND VEGFB SIGNALING; CANCER CELL MIGRATION; INVASIVENESS
RP   AND ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1.
RX   PubMed=15735759; DOI=10.1038/sj.onc.1208246;
RA   Fan F., Wey J.S., McCarty M.F., Belcheva A., Liu W., Bauer T.W.,
RA   Somcio R.J., Wu Y., Hooper A., Hicklin D.J., Ellis L.M.;
RT   "Expression and function of vascular endothelial growth factor receptor-1
RT   on human colorectal cancer cells.";
RL   Oncogene 24:2647-2653(2005).
RN   [27]
RP   FUNCTION IN CELL MIGRATION AND PHOSPHORYLATION OF PTK2/FAK1; YES1 AND SRC.
RX   PubMed=16685275; DOI=10.1038/sj.bjc.6603143;
RA   Lesslie D.P., Summy J.M., Parikh N.U., Fan F., Trevino J.G., Sawyer T.K.,
RA   Metcalf C.A., Shakespeare W.C., Hicklin D.J., Ellis L.M., Gallick G.E.;
RT   "Vascular endothelial growth factor receptor-1 mediates migration of human
RT   colorectal carcinoma cells by activation of Src family kinases.";
RL   Br. J. Cancer 94:1710-1717(2006).
RN   [28]
RP   MUTAGENESIS OF ASN-1050.
RX   PubMed=16286478; DOI=10.1074/jbc.m506454200;
RA   Meyer R.D., Mohammadi M., Rahimi N.;
RT   "A single amino acid substitution in the activation loop defines the decoy
RT   characteristic of VEGFR-1/FLT-1.";
RL   J. Biol. Chem. 281:867-875(2006).
RN   [29]
RP   FUNCTION IN PGF AND VEGFA SIGNALING; PHOSPHORYLATION OF AKT1; MAPK3/ERK1
RP   AND MAP KINASES; CHEMOTAXIS AND ACTIVATION OF PHOSPHATIDYLINOSITOL
RP   3-KINASE, AND AUTOPHOSPHORYLATION IN RESPONSE TO PGF AND VEGFA.
RX   PubMed=18079407; DOI=10.1161/atvbaha.107.158022;
RA   Tchaikovski V., Fellbrich G., Waltenberger J.;
RT   "The molecular basis of VEGFR-1 signal transduction pathways in primary
RT   human monocytes.";
RL   Arterioscler. Thromb. Vasc. Biol. 28:322-328(2008).
RN   [30]
RP   FUNCTION IN ENDOTHELIAL CELL SURVIVAL AND ANGIOGENESIS.
RX   PubMed=18583712; DOI=10.1161/circresaha.108.174128;
RA   Nishi J., Minamino T., Miyauchi H., Nojima A., Tateno K., Okada S.,
RA   Orimo M., Moriya J., Fong G.H., Sunagawa K., Shibuya M., Komuro I.;
RT   "Vascular endothelial growth factor receptor-1 regulates postnatal
RT   angiogenesis through inhibition of the excessive activation of Akt.";
RL   Circ. Res. 103:261-268(2008).
RN   [31]
RP   FUNCTION IN CANCER CELL MIGRATION AND ACTIVATION OF MAPK1/ERK2 AND/OR
RP   MAPK3/ERK1.
RX   PubMed=20551949; DOI=10.1038/sj.bjc.6605746;
RA   Taylor A.P., Leon E., Goldenberg D.M.;
RT   "Placental growth factor (PlGF) enhances breast cancer cell motility by
RT   mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement.";
RL   Br. J. Cancer 103:82-89(2010).
RN   [32]
RP   INTERACTION WITH RACK1.
RX   PubMed=21212275; DOI=10.1074/jbc.m110.165605;
RA   Wang F., Yamauchi M., Muramatsu M., Osawa T., Tsuchida R., Shibuya M.;
RT   "RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3-
RT   K/Akt pathway.";
RL   J. Biol. Chem. 286:9097-9106(2011).
RN   [33]
RP   INTERACTION WITH PSEN1 AND PTPRB, DEPHOSPHORYLATION BY PTPRB, MUTAGENESIS
RP   OF VAL-767, AND PROTEOLYTIC CLEAVAGE BY PSEN1 AT VAL-767.
RX   PubMed=22016384; DOI=10.1074/jbc.m111.296590;
RA   Cai J., Chen Z., Ruan Q., Han S., Liu L., Qi X., Boye S.L., Hauswirth W.W.,
RA   Grant M.B., Boulton M.E.;
RT   "gamma-Secretase and presenilin mediate cleavage and phosphorylation of
RT   vascular endothelial growth factor receptor-1.";
RL   J. Biol. Chem. 286:42514-42523(2011).
RN   [34]
RP   FUNCTION AS DECOY RECEPTORS; REGULATION OF VEGFA SIGNALING AND REGULATION
RP   OF KDR ACTIVITY (ISOFORMS 2/3/4), AND ROLE IN PREECLAMPSIA.
RX   PubMed=21752276; DOI=10.1186/2045-824x-3-15;
RA   Ahmad S., Hewett P.W., Al-Ani B., Sissaoui S., Fujisawa T., Cudmore M.J.,
RA   Ahmed A.;
RT   "Autocrine activity of soluble Flt-1 controls endothelial cell function and
RT   angiogenesis.";
RL   Vasc. Cell 3:15-15(2011).
RN   [35]
RP   REVIEW ON FUNCTION AS NEGATIVE REGULATOR OF ANGIOGENESIS DURING EMBRYONIC
RP   DEVELOPMENT; POSITIVE REGULATION OF MACROPHAGE FUNCTION IN ADULTHOOD; ROLE
RP   IN CARCINOGENESIS AND INFLAMMATION.
RX   PubMed=17002866; DOI=10.5483/bmbrep.2006.39.5.469;
RA   Shibuya M.;
RT   "Differential roles of vascular endothelial growth factor receptor-1 and
RT   receptor-2 in angiogenesis.";
RL   J. Biochem. Mol. Biol. 39:469-478(2006).
RN   [36]
RP   REVIEW ON STRUCTURE AND FUNCTION.
RX   PubMed=18680722; DOI=10.1016/j.bbrc.2008.07.121;
RA   Roskoski R. Jr.;
RT   "VEGF receptor protein-tyrosine kinases: structure and regulation.";
RL   Biochem. Biophys. Res. Commun. 375:287-291(2008).
RN   [37]
RP   REVIEW ON ROLE IN ANGIOGENESIS AND CANCER.
RX   PubMed=19230644; DOI=10.1016/j.ceb.2008.12.012;
RA   Lohela M., Bry M., Tammela T., Alitalo K.;
RT   "VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.";
RL   Curr. Opin. Cell Biol. 21:154-165(2009).
RN   [38]
RP   REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND
RP   SIGNALING.
RX   PubMed=19761875; DOI=10.1016/j.bbapap.2009.09.002;
RA   Grunewald F.S., Prota A.E., Giese A., Ballmer-Hofer K.;
RT   "Structure-function analysis of VEGF receptor activation and the role of
RT   coreceptors in angiogenic signaling.";
RL   Biochim. Biophys. Acta 1804:567-580(2010).
RN   [39]
RP   REVIEW ON ROLE IN CANCER.
RX   PubMed=20127948; DOI=10.1002/cncr.24789;
RA   Schwartz J.D., Rowinsky E.K., Youssoufian H., Pytowski B., Wu Y.;
RT   "Vascular endothelial growth factor receptor-1 in human cancer: concise
RT   review and rationale for development of IMC-18F1 (Human antibody targeting
RT   vascular endothelial growth factor receptor-1).";
RL   Cancer 116:1027-1032(2010).
RN   [40]
RP   REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND
RP   SIGNALING.
RX   PubMed=21711246; DOI=10.1042/bj20110301;
RA   Koch S., Tugues S., Li X., Gualandi L., Claesson-Welsh L.;
RT   "Signal transduction by vascular endothelial growth factor receptors.";
RL   Biochem. J. 437:169-183(2011).
RN   [41]
RP   REVIEW ON ROLE IN CANCER AND PREECLAMPSIA.
RX   PubMed=21558755; DOI=10.2183/pjab.87.167;
RA   Shibuya M.;
RT   "Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.";
RL   Proc. Jpn. Acad., B, Phys. Biol. Sci. 87:167-178(2011).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 132-226 IN COMPLEX WITH VEGFA, AND
RP   DOMAIN.
RX   PubMed=9393862; DOI=10.1016/s0092-8674(00)80456-0;
RA   Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A.,
RA   de Vos A.M.;
RT   "Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of
RT   the Flt-1 receptor.";
RL   Cell 91:695-704(1997).
RN   [43]
RP   STRUCTURE BY NMR OF 129-229, X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF
RP   129-229 IN COMPLEX WITH VEGFA, SUBUNIT, AND INTERACTION WITH VEGFA.
RX   PubMed=10543948; DOI=10.1006/jmbi.1999.3134;
RA   Starovasnik M.A., Christinger H.W., Wiesmann C., Champe M.A., de Vos A.M.,
RA   Skelton N.J.;
RT   "Solution structure of the VEGF-binding domain of Flt-1: comparison of its
RT   free and bound states.";
RL   J. Mol. Biol. 293:531-544(1999).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 130-229 IN COMPLEX WITH PGF.
RX   PubMed=14684734; DOI=10.1074/jbc.m313237200;
RA   Christinger H.W., Fuh G., de Vos A.M., Wiesmann C.;
RT   "The crystal structure of placental growth factor in complex with domain 2
RT   of vascular endothelial growth factor receptor-1.";
RL   J. Biol. Chem. 279:10382-10388(2004).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS) OF 129-226 IN COMPLEX WITH VEGFB,
RP   INTERACTION WITH VEGFB, SUBUNIT, AND DOMAIN.
RX   PubMed=20501651; DOI=10.1074/jbc.m110.130658;
RA   Iyer S., Darley P.I., Acharya K.R.;
RT   "Structural insights into the binding of vascular endothelial growth
RT   factor-B by VEGFR-1(D2): recognition and specificity.";
RL   J. Biol. Chem. 285:23779-23789(2010).
RN   [46]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-60; LYS-144; GLN-281; ILE-422; GLN-781;
RP   VAL-938; ALA-982 AND VAL-1061.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Flt1;
CC         IsoId=P17948-1; Sequence=Displayed;
CC       Name=2; Synonyms=sFlt1;
CC         IsoId=P17948-2; Sequence=VSP_002955, VSP_002956;
CC       Name=3; Synonyms=sFlt1-14;
CC         IsoId=P17948-3; Sequence=VSP_041927, VSP_041928;
CC       Name=4;
CC         IsoId=P17948-4; Sequence=VSP_041929, VSP_041930;
CC       Name=5; Synonyms=i15;
CC         IsoId=P17948-5; Sequence=VSP_041985;
CC       Name=6; Synonyms=i18;
CC         IsoId=P17948-6; Sequence=VSP_041984;
CC       Name=7; Synonyms=i21;
CC         IsoId=P17948-7; Sequence=VSP_041983;
CC       Name=8;
CC         IsoId=P17948-8; Sequence=VSP_047759, VSP_047760;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   Ensembl; ENST00000543394.2; ENSP00000437841.1; ENSG00000102755.12.
DR   Proteomes; UP000005640; Chromosome 13.
PE   1: Evidence at protein level;
SQ   SEQUENCE   361 AA;  41175 MW;  34E2B38DE128BA53 CRC64;
     MNSDLLVDSD GFYKEPITME DLISYSFQVA RGMEFLSSRK CIHRDLAARN ILLSENNVVK
     ICDFGLARDI YKNPDYVRKG DTRLPLKWMA PESIFDKIYS TKSDVWSYGV LLWEIFSLGG
     SPYPGVQMDE DFCSRLREGM RMRAPEYSTP EIYQIMLDCW HRDPKERPRF AELVEKLGDL
     LQANVQQDGK DYIPINAILT GNSGFTYSTP AFSEDFFKES ISAPKFNSGS SDDVRYVNAF
     KFMSLERIKT FEELLPNATS MFDDYQGDSS TLLASPMLKR FTWTDSKPKA SLKIDLRVTS
     KSKESGLSDV SRPSFCHSSC GHVSEGKRRF TYDHAELERK IACCSPPPDY NSVVLYSTPP
     I
//
